Skip to results
Modify your search
NARROW
1-19 of 19
Authors: Susanne Jacobsson
Sort by
Journal Article
Exceedingly high levels of tetracycline resistance in Neisseria gonorrhoeae in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021–2024—doxycycline post-exposure prophylaxis will unlikely impact gonorrhoea burdens
Get access
Daniel Schröder and others
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 5, May 2025, Pages 1291–1295, https://doi.org/10.1093/jac/dkaf066
Published: 18 March 2025
Journal Article
Probing fosfomycin’s potential: a study on susceptibility testing and resistance in Staphylococcus epidermidis from prosthetic joint infections
Get access
Rebecka Widerström and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 11, November 2024, Pages 2948–2953, https://doi.org/10.1093/jac/dkae312
Published: 06 September 2024
Journal Article
In silico gepotidacin target mining among 33 213 global Neisseria gonorrhoeae genomes from 1928 to 2023 combined with gepotidacin MIC testing of 22 gonococcal isolates with different GyrA and ParC substitutions Open Access
Alexandra David and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 9, September 2024, Pages 2221–2226, https://doi.org/10.1093/jac/dkae217
Published: 08 July 2024
Journal Article
The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains—phenotypic, genetic and reference genome characterization Open Access
Magnus Unemo and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 8, August 2024, Pages 1885–1899, https://doi.org/10.1093/jac/dkae176
Published: 21 June 2024
Journal Article
Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125–1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea Free
Magnus Unemo and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1006–1013, https://doi.org/10.1093/jac/dkae063
Published: 18 March 2024
Journal Article
Antimicrobial susceptibility in Neisseria gonorrhoeae and epidemiological data of gonorrhoea patients in five cities across Ethiopia, 2021–22 Open Access
Muluken Birhanu and others
JAC-Antimicrobial Resistance, Volume 6, Issue 1, February 2024, dlae002, https://doi.org/10.1093/jacamr/dlae002
Published: 01 February 2024
Journal Article
Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015–20 Free
Francis Kakooza and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 8, August 2023, Pages 1982–1991, https://doi.org/10.1093/jac/dkad193
Published: 23 June 2023
Journal Article
High-level in vitro resistance to gentamicin acquired in a stepwise manner in Neisseria gonorrhoeae
Get access
Daniel Golparian and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 7, July 2023, Pages 1769–1778, https://doi.org/10.1093/jac/dkad168
Published: 30 May 2023
Journal Article
GyrB in silico mining in 27 151 global gonococcal genomes from 1928–2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility Free
Daniel Golparian and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 150–154, https://doi.org/10.1093/jac/dkac366
Published: 29 October 2022
Journal Article
Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018 Free
Daniel Golparian and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 8, August 2022, Pages 2171–2182, https://doi.org/10.1093/jac/dkac158
Published: 11 May 2022
Journal Article
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018 Free
Magnus Unemo and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 5, May 2021, Pages 1221–1228, https://doi.org/10.1093/jac/dkab024
Published: 10 February 2021
Journal Article
EDITOR'S CHOICE
Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae Free
Ronza Hadad and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 1, January 2021, Pages 84–90, https://doi.org/10.1093/jac/dkaa381
Published: 15 September 2020
Journal Article
High in vitro activity of DIS-73285, a novel antimicrobial with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae Open Access
Susanne Jacobsson and others
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3244–3247, https://doi.org/10.1093/jac/dkaa322
Published: 26 July 2020
Journal Article
In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea? Open Access
Susanne Jacobsson and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 6, June 2019, Pages 1591–1594, https://doi.org/10.1093/jac/dkz060
Published: 18 February 2019
Journal Article
In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae Free
Susanne Jacobsson and others
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 8, August 2018, Pages 2072–2077, https://doi.org/10.1093/jac/dky162
Published: 22 May 2018
Journal Article
The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization Free
Magnus Unemo and others
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 11, November 2016, Pages 3096–3108, https://doi.org/10.1093/jac/dkw288
Published: 17 July 2016
Journal Article
WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014 Free
Susanne Jacobsson and others
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 11, November 2016, Pages 3109–3116, https://doi.org/10.1093/jac/dkw279
Published: 17 July 2016
Journal Article
In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains
Get access
Susanne Jacobsson and others
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 1, January 2015, Pages 173–177, https://doi.org/10.1093/jac/dku344
Published: 01 September 2014
Journal Article
Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains
Get access
David M. Whiley and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 12, December 2010, Pages 2543–2547, https://doi.org/10.1093/jac/dkq377
Published: 12 October 2010